FdaApplication
ANDA 204733
Identifiers
- fda_app_no: ANDA204733
Properties
| Property | Value |
|---|---|
| applicant_name | AUROLIFE PHARMA LLC |
| application_type | ANDA |
| approval_date | 2018-09-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | 325MG;50MG;40MG | CAPSULE;ORAL |
1 product